Probiodrug to Present Novel Causative Treatment Approach for Alzheimer’s Disease

Probiodrug Receives Research Grant of €1.9 million
Probiodrug announces appointment of Prof Dr Harald Labischinski and Dr Jonathan David Turner to its Board of Directors